Flowserve Q2 EPS $0.37 Misses $0.41 Estimate, Sales $898.18M Beat $896.32M Estimate

Flowserve (NYSE:FLS) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.41 by 9.76 percent. This is a 30.19 percent decrease over earnings of $0.53 per share from the same

Flowserve (NYSE:FLS) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.41 by 9.76 percent. This is a 30.19 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $898.18 million which beat the analyst consensus estimate of $896.32 million by 0.21 percent. This is a 2.90 percent decrease over sales of $924.97 million the same period last year.

Total
0
Shares
Related Posts
Read More

HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, announced on Thursday its entry into an exclusive U.S.

CSE:HAVN